Search clinical trials for: Citalopram Hydrobromide

Total 664 results

Vigonvita Life Sciences

Completed

A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

Healthy Subjects

China
Hartford Hospital
Spero Therapeutics

Completed

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Diabetes | ABSSSI | Healthy Volunteers | Wound Infection

United States
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Escitalopram

Obesity, Morbid

Norway
Vigonvita Life Sciences

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Respiratory Syncytial Virus Infections

China
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Healthy Subjects | Subjects With Renal Impairment

China
Spero Therapeutics

Completed

Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Healthy Volunteers

United States
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

A Study in Elderly Chinese Subjects With Underlying Diseases

Elderly Subjects With Underlying Diseases

China
St. Luke's-Roosevelt Hospital Center
Forest Laboratories

Completed

Escitalopram in the Treatment of Dysthymic Disorder, Double Blind

Dysthymic Disorder

United States
Vigonvita Life Sciences

Recruiting

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Respiratory Syncytial Virus Infection

China
Torrent Pharmaceuticals Limited

Completed

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

Healthy

India
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Citalopram in Treating Postmenopausal Women With Hot Flashes

Breast Cancer | Hot Flashes | Psychosocial Effects of Cancer and Its Treatment

United States
Torrent Pharmaceuticals Limited

Completed

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

Healthy

India
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Completed

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

Subjects With Liver Function Injury | Normal Liver Function Subject

China
Mayo Clinic
National Institute of General Medical Sciences (NIGMS); National Center for...

Completed

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram (PGRN-SSRI)

Depression

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Healthy

Canada
Boston University
National Institute of Mental Health (NIMH)

Completed

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

Autistic Disorder

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions

Healthy

Canada
Spero Therapeutics

Completed

Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function

Renal Impairment

United States
Centre for Addiction and Mental Health
Queen's University

Completed

Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression

Depression

Canada
Massachusetts General Hospital

Completed

Biological Markers of Response to Treatment in Major Depressive Disorder

Major Depressive Disorder
University of Nebraska

Recruiting

A Study Utilizing Escitalopram in Glioma Patients

Glioma | Glioma of Brain

United States
University of Pittsburgh
National Institute of Mental Health (NIMH)

Completed

Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety

Depression | Anxiety

United States
First Affiliated Hospital of Zhejiang University

Recruiting

Development and Application of Comprehensive Intervention Techniques for Adolescent Depression

Adolescent | Depressive Disorder

China
Spero Therapeutics
Celerion

Completed

A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects

TQT Study

United States
Shanghai 7th People's Hospital

Not yet recruiting

Acupuncture and Escitalopram for Treating Major Depression Clinical Study (AE-TMDCS)

Depressive Disorder, Major

China
Shanghai Mental Health Center
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression

Depression

China
Shanghai Mental Health Center

Recruiting

A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment

Major Depressive Disorder

China
University of Pennsylvania
Washington University School of Medicine

Completed

Escitalopram Effects on CSF Amyloid Beta

Amyloid Beta Protein

United States
Oregon Health and Science University
Forest Laboratories

Completed

Circadian Effects of Escitalopram

Depression

United States
Samsung Medical Center
H. Lundbeck A/S

Unknown

Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning

Depression | Adverse Reaction to Drug | Continuous Antidepressant Abuse

Korea, Republic of
Duke University
Forest Laboratories

Completed

Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

Atypical Depression

United States
Johns Hopkins University
Medical University of South Carolina; University of South Carolina; University... and other collaborators

Recruiting

Escitalopram and Language Intervention for Subacute Aphasia (ELISA)

Stroke | Aphasia

United States
Handok Inc.

Recruiting

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin (TERA 305)

Type 2 Diabetes

Korea, Republic of
Handok Inc.

Recruiting

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin (TERA 304)

Type 2 Diabetes

Korea, Republic of
Tri-Service General Hospital

Completed

Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems

Anxiety Disorders | Sleep Apnea

Taiwan
Kunming Medical University
Chinese Academy of Sciences

Completed

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

Depression | Depression Secondary to Other Disease

China
VA Nebraska Western Iowa Health Care System
Forest Laboratories

Completed

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

PTSD

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Treatment Response of Geriatric Depression (ERP)

Depression

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

fMRI Studies of Emotional Brain Circuitry in People With Major Depression

Depression
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms (Lexapro)

Depressive Disorder, Major

China
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Aging Brain Changes, Executive Dysfunction and Depression (FA)

Depression
Weill Medical College of Cornell University

Completed

Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression

Depression

United States
Massachusetts General Hospital
Forest Laboratories

Completed

Influence of Escitalopram on Fear Conditioning

Fear Conditioning
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Biomarkers for Outcomes In Late-life Depression (BOLD) (BOLD)

Major Depressive Disorder

United States
Seoul National University Hospital

Unknown

Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

Korea, Republic of
Beitou Armed Forces Hospital, Taipei, Taiwan

Unknown

The Effects of Escitalopram on Cytokines (BAFH)

Depression

Taiwan
Pharmacology Research Institute

Unknown

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Charite University, Berlin, Germany
H. Lundbeck A/S

Completed

Investigation of a Combination Treatment of Escitalopram and rTMS

Major Depressive Disorder

Germany
Community Pharmacology Services Ltd

Completed

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Major Depressive Disorder

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)

Depression | Anxiety | In Vitro Fertilization

Israel

Search clinical trials for: Citalopram Hydrobromide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations